Nnc 55-0396
| Title | Journal |
|---|---|
| Zinc deficiency promotes cystitis-related bladder pain by enhancing function and expression of Ca(v)3.2 in mice. | Toxicology 20180115 |
| Involvement of the endogenous hydrogen sulfide/Ca(v) 3.2 T-type Ca2+ channel pathway in cystitis-related bladder pain in mice. | British journal of pharmacology 20121001 |
| Calcium influx through a possible coupling of cation channels impacts skeletal muscle satellite cell activation in response to mechanical stretch. | American journal of physiology. Cell physiology 20120615 |
| The CatSper channel: a polymodal chemosensor in human sperm. | The EMBO journal 20120404 |
| Atypical Ca2+ currents in chromaffin cells from SHR and WKY rat strains result from the deficient expression of a splice variant of the α1D Ca2+ channel. | American journal of physiology. Heart and circulatory physiology 20120101 |
| Inhibition of T-type calcium channels and hydrogen sulfide-forming enzyme reverses paclitaxel-evoked neuropathic hyperalgesia in rats. | Neuroscience 20110811 |
| Modulation of subthalamic T-type Ca(2+) channels remedies locomotor deficits in a rat model of Parkinson disease. | The Journal of clinical investigation 20110801 |
| Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation. | Cancer investigation 20110601 |
| Basal sympathetic activity generated in neonatal mouse brainstem-spinal cord preparation requires T-type calcium channel subunit 1H. | Experimental physiology 20110501 |
| The CatSper channel mediates progesterone-induced Ca2+ influx in human sperm. | Nature 20110317 |
| T-type calcium channel antagonists suppress tremor in two mouse models of essential tremor. | Neuropharmacology 20101101 |
| Actions of thalidomide in producing vascular relaxations. | European journal of pharmacology 20101010 |
| Effects of T-type calcium channel blockers and thalidomide on contractions of rat vas deferens. | British journal of pharmacology 20100301 |
| Selective blockade of T-type Ca2+ channels suppresses human breast cancer cell proliferation. | Cancer letters 20080818 |
| Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC 55-0396. | Cardiovascular drug reviews 20050101 |
| NNC 55-0396 [(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels. | The Journal of pharmacology and experimental therapeutics 20040401 |